'Medical AI' DEEPNOID, goes IPO Promotion

October 30, 2018


Shinhan Investment Co. prepares exclusive technical listing ... Focuses on the medical image analysis solution 'DEEP: PHI.'


DEEPNOID, a medical AI company founded in 2008, will promote Initial Public Offering (IPO). After signing a contract with Shinhan Investment Co., DEEPNOID, which started working on the IPO, is striving to enter the KOSDAQ the following year. The main business area is medical AI, specifically creating an accurate and objective medical image reading standards by designing a solution model that helps the doctor's reading process.





Share on Facebook
Share on Twitter
Please reload

Featured Posts

"근골격계질환 의료AI로 2021년 미국 시장 진출하겠다"

June 10, 2019

Please reload

Recent Posts
Please reload


©2019 DEEPNOID Inc.